CytoSorbents (USA) and Aferetica announce the European Union's approval for clinical use of the integrated PerLife® system and the "PerSorb ECOS-300CY ™" sorbent
Second update on the news related to the possible use of CytoSorb as an adjuvant therapy against some complications in patients with severe COVID-19 infection
We consider important to share an update on the news related to the possible use of CytoSorb as an adjuvant therapy against some complications in patients with severe infection with COVID-19
In the recent days, we have witnessed the multiplication of [...]
We are proud to announce that from today the fight against the Sepsis, the world's leading cause of hospital death, has a new ally.
CytoSorb® Registry is an independent international registry coordinated by the University Hospital of Jena and aimed at collecting data of all patients treated with CytoSorb®.
Proceeding with the path started in January 2017, Aferetica announces the new edition of Workshop ‘Purification Therapies’ which will be held in Milan, at the Cariplo Centro Congressi, on March 15-16, 2019.
Official Video of the First Workshop “Purification Therapies” is now online
